Earnings History Data for Lexicon Pharmaceuticals (LXRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Lexicon Pharmaceuticals

Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones. The Company uses an integrated platform of functional genomictechnologies to accelerate large-scale analysis of mammalian gene function for drug discovery.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
11-03-2024	PM		LXRX	Lexicon Pharmaceuticals	527.00	-0.20	-0.23	0.00	Lexicon Pharmaceuticals GAAP EPS of -$0.20 beats by $0.02, revenue of $0.7M misses by $0.54M [3/11/2024 12:13 PM]	2.80	0.63 (29.16%)	2.32	0.15 (6.95%)	0.92 - 3.79	27,254,547	3,560,000	1,674,834
Lexicon announces oversubscribed $250M private placement of equity securities [3/11/2024 11:52 AM] Lexicon stock rallies 18% amid FDA update, $250M private placement [3/11/2024 12:15 PM] Lexicon Pharmaceuticals GAAP EPS of -$0.20 beats by $0.02, revenue of $0.7M misses by $0.54M [3/11/2024 12:13 PM]
08-11-2023	PM		LXRX	Lexicon Pharmaceuticals, Inc.	315.95	-0.21	-0.22	-0.13	Lexicon Pharmaceuticals GAAP EPS of -$0.21 in-line, revenue of $0.16M misses by $1.9M [11/8/2023 7:08 AM]	1.14	-0.11 (-8.80%)	1.13	-0.12 (-9.60%)	0.96 - 3.79	4,102,539	2,060,000	180,742
Lexicon Pharmaceuticals Q3 2023 Earnings Preview [11/7/2023 11:49 AM] Lexicon Pharmaceuticals GAAP EPS of -$0.21 in-line, revenue of $0.16M misses by $1.9M [11/8/2023 7:08 AM]
03-08-2023	AH		LXRX	Lexicon Pharmaceuticals, Inc.	367.75	-0.22	-0.17	-0.16	Lexicon Pharmaceuticals GAAP EPS of -$0.22, revenue of $0.32M [8/3/2023 4:09 PM]	1.86	-0.05 (-2.86%)	1.83	-0.09 (-4.69%)	1.71 - 3.79	3,002,074	1,500,000	43,478
Lexicon Pharmaceuticals GAAP EPS of -$0.22, revenue of $0.32M [8/3/2023 4:09 PM]
02-05-2023	AH	4:00 PM ET (May 2)	LXRX	Lexicon Pharmaceuticals, Inc.	451.05	-0.17	-0.17	-0.16	Lexicon Pharmaceuticals GAAP EPS of -$0.17 beats by $0.01, revenue of $0.02M misses by $0.01M [5/2/2023 4:32 PM]	2.76	0.38 (15.97%)	2.48	0.10 (4.20%)	1.31 - 3.48	1,845,092	540,000	16,035
Lexicon Pharmaceuticals GAAP EPS of -$0.17 beats by $0.01, revenue of $0.02M misses by $0.01M [5/2/2023 4:32 PM]
02-03-2023	AH		LXRX	Lexicon Pharmaceuticals, Inc.	445.39	-0.16	-0.14	-0.17	Lexicon Pharmaceuticals GAAP EPS of -$0.16 misses by $0.03, revenue of $0.03M misses by $0.02M [3/2/2023 4:01 PM]	2.68	0.50 (22.94%)	2.19	0.01 (0.46%)	1.31 - 3.48	1,646,903	390,000	49,502
Lexicon Pharmaceuticals GAAP EPS of -$0.16 misses by $0.03, revenue of $0.03M misses by $0.02M [3/2/2023 4:01 PM]
09-11-2022	AH	4:00 PM ET (Nov 9)	LXRX	Lexicon Pharmaceuticals, Inc.	401.99	-0.13	-0.15	-0.16	Lexicon Pharmaceuticals GAAP EPS of -$0.13 [11/9/2022 4:03 PM]	2.23	0.27 (13.52%)	1.96	0.0 (0.00%)	1.31 - 5.28	518,405	370,000	5,487
Lexicon Pharmaceuticals GAAP EPS of -$0.13 [11/9/2022 4:03 PM] Lexicon Pharmaceuticals Highlights Oral Presentation of Final Results From the RELIEF-DPN-1 Trial of LX9211 at the 16th Annual Pain Therapeutics Summit [Nov-08-22 08:58AM]
02-08-2022	AH	4:00 PM ET (Aug 2)	LXRX	Lexicon Pharmaceuticals, Inc.	460.75	-0.16	-0.15	-0.13	Lexicon Pharmaceuticals GAAP EPS of -$0.16 in-line, revenue of $0.04M misses by $0.06M [8/2/2022 4:32 PM]	2.68	0.08 (3.08%)	2.64	0.04 (1.54%)	1.31 - 6.33	1,576,651	1,860,000	55,147
Lexicon Pharmaceuticals GAAP EPS of -$0.16 in-line, revenue of $0.04M misses by $0.06M [8/2/2022 4:32 PM] Lexicon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-02-22 04:01PM]
05-05-2022	PM	6:00 AM ET (May 5)	LXRX	Lexicon Pharmaceuticals, Inc.	288.72	-0.16	-0.16	-0.15	Lexicon Pharmaceuticals GAAP EPS of -$0.16 beats by $0.01, revenue of $0.04M misses by $0.01M [5/5/2022 6:11 AM]	1.84	-0.10 (-5.15%)	1.94	0.0 (0.00%)	1.79 - 6.33	269,023	430,000	166
Lexicon Pharmaceuticals Q1 Earnings Preview [5/4/2022 3:03 PM] Lexicon Pharmaceuticals GAAP EPS of -$0.16 beats by $0.01, revenue of $0.04M misses by $0.01M [5/5/2022 6:11 AM] Lexicon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical Update [May-05-22 06:00AM]
28-02-2022	PM	Before the open (Feb 28)	LXRX	Lexicon Pharmaceuticals	432.00	-0.17	-0.17	0.00	Lexicon Pharmaceuticals GAAP EPS of -$0.17 beats by $0.01, revenue of $0.01M [2/28/2022 6:05 AM]	2.05	-0.80 (-28.07%)	2.45	-0.40 (-14.04%)	2.05 - 7.78	2,613,503	470,000	53,379
Lexicon Pharmaceuticals GAAP EPS of -$0.17 beats by $0.01, revenue of $0.01M [2/28/2022 6:05 AM] Lexicon pulls U.S. marketing application for heart disease drug [2/28/2022 8:37 AM] Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Clinical Update [Feb-28-22 06:01AM] Lexicon Voluntarily Withdraws Sotagliflozin New Drug Application and Plans Prompt Resubmission Targeted Early Q2 2022 [Feb-28-22 06:00AM] Lexicon Pharmaceuticals to Host Fourth Quarter 2021 Financial Results Conference Call and Webcast on February 28, 2022 [Feb-25-22 09:03PM] Why Lexicon Pharmaceuticals Was Plunging on Monday [Feb-28-22 04:54PM]
03-11-2021	AH	4:05 PM ET (Nov 3)	LXRX	Lexicon Pharmaceuticals, Inc.	820.61	-0.16	-0.18	0.71	Lexicon Pharmaceuticals EPS beats by $0.02 [11/3/2021 4:16 PM]	4.97	-0.80 (-13.86%)	5.52	-0.25 (-4.33%)	1.03 - 9.65	974,981	550,000	8,777
Lexicon Pharmaceuticals EPS beats by $0.02 [11/3/2021 4:16 PM] Lexicon Pharmaceuticals falls 8% despite Q3 earnings beat [11/3/2021 5:32 PM] Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical Update [Nov-03-21 04:02PM]
30-07-2021	PM		LXRX	Lexicon Pharmaceuticals, Inc.	488.03	-0.13	-0.16	-0.64	Lexicon Pharmaceuticals EPS beats by $0.03, beats on revenue [7/30/2021 7:22 AM]	3.52	-0.06 (-1.68%)	3.65	0.07 (1.96%)	1.03 - 9.65	845,124	590,000	8,046
Lexicon Pharmaceuticals appoints Craig Granowitz as Chief Medical Officer [7/30/2021 7:08 AM] Lexicon Pharmaceuticals EPS beats by $0.03, beats on revenue [7/30/2021 7:22 AM] Lexicon Pharmaceuticals to Host Second Quarter 2021 Financial Results Conference Call and Webcast on July 30, 2021 [Jul-28-21 05:40PM] Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical Officer [Jul-30-21 07:01AM] Lexicon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical Update [Jul-30-21 07:00AM] Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue Estimates [Jul-30-21 08:35AM]
06-05-2021	AH	4:10 PM ET (May 6)	LXRX	Lexicon Pharmaceuticals, Inc.	668.36	-0.15	-0.17	-0.63	Lexicon Pharmaceuticals EPS beats by $0.02 [5/6/2021 4:20 PM]	4.58	0.12 (2.69%)	4.58	0.0 (0.00%)	1.03 - 9.65	589,048	750,000	5,333
Lexicon Pharmaceuticals EPS beats by $0.02 [5/6/2021 4:20 PM] Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update [May-06-21 04:05PM] Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Lags Revenue Estimates [May-06-21 08:35PM]
10-03-2021	AH	4:45 PM ET (Mar 10)	LXRX	Lexicon Pharmaceuticals, Inc.	952.98	-0.05	-0.28	-0.48	Lexicon Pharmaceuticals EPS beats by $0.25, beats on revenue [3/10/2021 4:14 PM]	6.99	-0.31 (-4.25%)	7.54	0.24 (3.29%)	1.03 - 9.65	1,682,503	1,304,739	17,071
Lexicon Pharmaceuticals EPS beats by $0.25, beats on revenue [3/10/2021 4:14 PM] Lexicon Pharmaceuticals, Inc. to Host Earnings Call [Mar-10-21 02:15PM] Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Clinical Update [Mar-10-21 04:10PM] Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates [Mar-10-21 05:55PM]
29-10-2020	PM	7:00 AM ET (Oct 29)	LXRX	Lexicon Pharmaceuticals, Inc.	141.00	0.71	0.45	0.00	Lexicon Pharmaceuticals EPS of $0.71 [10/29/2020 6:07 AM]	1.16	-0.06 (-4.92%)	1.23	0.01 (0.82%)	1.12 - 5.33	1,235,696	728,430	20,235

30-07-2020	PM	7:00 AM ET (Jul 30)	LXRX	Lexicon Pharmaceuticals, Inc.	186.13	-0.64	-0.56	-0.22	Lexicon Pharmaceuticals EPS misses by $0.04, beats on revenue [7/30/2020 7:02 AM]	1.90	0.16 (9.20%)	2.02	0.28 (16.09%)	1.12 - 5.33	9,900,542	4,162,446	3,287,921